Phenotypic detection of resistance mechanisms in gram-positive bacteria

被引:11
|
作者
Isabel Morosini, Maria [1 ]
Cercenado, Emilia [2 ]
Ardanuy, Carmen [3 ]
Torres, Carmen [4 ]
机构
[1] Hosp Univ Ramon y Cajal, Serv Microbiol, Madrid, Spain
[2] Hosp Gen Univ Gregorio Maranon, Serv Microbiol, Madrid, Spain
[3] Hosp Univ Bellvitge, Serv Microbiol, Barcelona, Spain
[4] Univ La Rioja, Area Bioquim & Biol Mol, Logrono, Spain
来源
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA | 2012年 / 30卷 / 06期
关键词
Staphylococcus; Enterococcus; Streptococcus pneumoniae; Antibiogram; Resistance phenotypes; INDUCIBLE CLINDAMYCIN RESISTANCE; STAPHYLOCOCCUS-AUREUS; STREPTOCOCCUS-PNEUMONIAE; TESTING SUSCEPTIBILITY; CLINICAL IMPLICATIONS; ENTEROCOCCUS-FAECIUM; MUPIROCIN; OXACILLIN;
D O I
10.1016/j.eimc.2011.09.009
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Antimicrobial resistance mechanisms among clinically relevant gram-positive microorganisms can be demonstrated using phenotypic tests that enable the interpretation of underlying mechanisms responsible for the in vitro resistance. The reporting of these mechanisms, either inferred or demonstrated, helps in the adjustment of clinical treatments and the epidemiological follow up of resistance traits. In the present work, phenotypic tests for detection of antimicrobial resistance mechanisms involving the most frequent antimicrobial families used against Staphylococcus spp., Enterococcus spp. and Streptococcus pneumoniae are analysed. In the case of Staphylococcus, phenotypic tests to reveal the mechanisms of resistance against beta-lactams, macrolides, lincosamides and streptogramin B (MLSB), as well as intermediate susceptibility to glycopeptides, resistance to aminoglycosides, mupirocin and linezolid are reviewed. Tests to detect glycopeptide resistance and high-level aminoglycoside resistance among enterococci are analysed. Detection of penicillin resistance, as well as diminished susceptibility to third generation cephalosporins, together with diminished susceptibility or even resistance to fluoroquinolones is also detailed. (c) 2011 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:325 / 332
页数:8
相关论文
共 50 条
  • [11] Resistance of Gram-Positive Bacteria to Current Antibacterial Agents and Overcoming Approaches
    Jubeh, Buthaina
    Breijyeh, Zeinab
    Karaman, Rafik
    MOLECULES, 2020, 25 (12):
  • [12] Resistance to bacteriocins produced by Gram-positive bacteria
    de Freire Bastos, Maria do Carmo
    Varella Coelho, Marcus Livio
    da Silva Santos, Olinda Cabral
    MICROBIOLOGY-SGM, 2015, 161 : 683 - 700
  • [13] Mechanisms of resistance to membrane-disrupting antibiotics in Gram-positive and Gram-negative bacteria
    Steinbuch, Kfir B.
    Fridman, Micha
    MEDCHEMCOMM, 2016, 7 (01) : 86 - 102
  • [14] Pilins in gram-positive bacteria: A structural perspective
    Krishnan, Vengadesan
    IUBMB LIFE, 2015, 67 (07) : 533 - 543
  • [15] National surveillance of antimicrobial resistance among Gram-positive bacteria in Saudi Arabia
    Shibl, Atef M.
    Memish, Ziad A.
    Kambal, Abdelmageed M.
    Ohaly, Yazid A.
    Ishaq, Abdulrahman
    Senok, Abiola C.
    Livermore, David M.
    JOURNAL OF CHEMOTHERAPY, 2014, 26 (01) : 13 - 18
  • [16] Application of subproteomics in the characterization of Gram-positive bacteria
    Yang, Xiao-Yan
    Lu, Jie
    Sun, Xuesong
    He, Qing-Yu
    JOURNAL OF PROTEOMICS, 2012, 75 (10) : 2803 - 2810
  • [17] Multidrug efflux pumps of Gram-positive bacteria
    Schindler, Bryan D.
    Kaatz, Glenn W.
    DRUG RESISTANCE UPDATES, 2016, 27 : 1 - 13
  • [18] Mechanisms of gram-positive vancomycin resistance (Review)
    Selim, Samy
    BIOMEDICAL REPORTS, 2022, 16 (01)
  • [19] Mechanisms of the Resistance and Tolerance to Beta-Lactam and Glycopeptide Antibiotics in Pathogenic Gram-Positive Cocci
    Mlynarczyk, A.
    Mlynarczyk, B.
    Kmera-Muszynska, M.
    Majewski, S.
    Mlynarczyk, G.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2009, 9 (13) : 1527 - 1537
  • [20] Antimicrobial Resistance and Infection Control for Gram-positive Bacteria
    Noguchi, Norihisa
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2021, 141 (02): : 235 - 244